IMV Inc (IMV.CA) Stock News

Canada - TSX:IMV - CA44974L3011 - Common Stock

1.12 CAD

-0.02 (-1.75%)

Last: 4/28/2023, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

IMV.CA Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: IMV Inc.

IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets

2 years ago - By: IMV Inc.

IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Receives NASDAQ Delisting Notice

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Initiates Restructuring Proceedings Under the CCAA to Complete the Review of its Strategic Alternatives

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Announces Changes to Its Board of Directors

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE Trial

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Announces US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCL

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Commences Trading on the TSX and Nasdaq Post-Reverse Stock Split

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Shareholders Approve Reverse Stock Split at 88%

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Receives Nasdaq Notification Regarding Market Value of Listed Securities

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Announces Third Quarter 2022 Financial and Operational Results

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. to Announce Third Quarter 2022 Results and Host a Conference Call and Webcast on November 11, 2022

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Provides an Update on The VITALIZE Trial

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Announces Strategic Reorganization

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. to Present at Two Investor Conferences in September

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Announces Second Quarter 2022 Financial and Operational Results

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Re-Establishes Its At-the-Market Facility Under Renewed Base Shelf Prospectus

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. to Announce Second Quarter 2022 Results and Host a Conference Call and Webcast on August 11, 2022

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Announces Annual and Special Meeting of Shareholders Voting Results

3 years ago - By: IMV Inc. - Mentions: IMV

IMV Strengthens Its Financial Position With the $US10 Million Drawdown From Its Existing Long-Term Debt Facility

4 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. to Present at the H.C. Wainwright Global Investment Conference

4 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Announces First Quarter 2022 Financial and Operational Results

4 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. to Announce First Quarter 2022 Results and Host a Conference Call and Webcast on May 13, 2022

4 years ago - By: IMV Inc. - Mentions: IMV

IMV’s Lead Compound to Be Showcased in Two Presentations at the 2022 ASCO Annual Meeting

4 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Names Michael P. Bailey Chairman of The Board

4 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Presents Clinical Benefit of MVP-S in Combination with Pembrolizumab in Bladder Cancer at the AACR Annual Meeting

4 years ago - By: IMV Inc. - Mentions: IMV

IMV to Present at IMMUNOLOGY™ 2022, the AAI Annual Meeting

4 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. to Present at Two Upcoming Investor Conferences

4 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. Announces Fourth Quarter and Full Year 2021 Financial and Operational Results

4 years ago - By: IMV Inc. - Mentions: IMV

IMV to Host a Webcast to Highlight its Immune-Educating DPX® Platform

4 years ago - By: IMV Inc. - Mentions: IMV

IMV Announces First Patient Dosed in the VITALIZE Phase 2B Clinical Study Evaluating its Lead Compound, MVP-S, in Combination with KEYTRUDA® (pembrolizumab) in Patients with r/r DLBCL

4 years ago - By: IMV Inc. - Mentions: IMV

IMV Inc. to Present at Two Upcoming Investor Events

4 years ago - By: IMV Inc. - Mentions: IMV

IMV Appoints Andrew Hall as Chief Executive Officer